Microwave Lung Ablation Complicated by Bronchocutaneous Fistula: Case Report and Literature Review

ABSTRACT

Microwave ablation is a developing treatment option for unresectable lung cancer. Early experience suggests that it may have advantages over radiofrequency (RF) ablation with larger ablation zones, shorter heating times, less susceptibility to heat sink, effectiveness in charred lung, synergism with multiple applicators, no need for grounding pads, and similar survival benefit. Newer microwave ablation devices are being developed and as their use becomes more prevalent, a greater understanding of device limitations and complications are important. Herein we describe a microwave lung ablation complicated by bronchocutaneous fistula (BCF) and its treatment. BCF treatment options include close monitoring, surgical closure, percutaneous sealant injection, and endoscopic plug or sealant in those who are not surgical candidates.

KEYWORDS

Microwave ablation - bronchopleural fistula - lung cancer treatment

REFERENCES

• 1 WHO .International Agency for Research on Cancer. GLOBOCAN 2008. Lyon, France: WHO; 2010
• 2 Dupuy D E, Zagoria R J, Akerley W, Mayo-Smith W W, Kavanagh P V, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung.  AJR Am J Roentgenol. 2000;  174 (1) 57-59
• 3 Chan V O, McDermott S, Malone D E, Dodd J D. Percutaneous radiofrequency ablation of lung tumors: evaluation of the literature using evidence-based techniques.  J Thorac Imaging. 2011 Feb;  26 (1) 18-26
• 4 Lencioni R, Crocetti L, Cioni R et al.. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).  Lancet Oncol. 2008;  9 (7) 621-628
• 5 Simon C J, Dupuy D E, DiPetrillo T A et al.. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.  Radiology. 2007;  243 (1) 268-275
• 6 Wolf F J, Grand D J, Machan J T, Dipetrillo T A, Mayo-Smith W W, Dupuy D E. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients.  Radiology. 2008;  247 (3) 871-879
• 7 Lubner M G, Brace C L, Hinshaw J L, Lee Jr FT. Microwave tumor ablation: mechanism of action, clinical results, and devices.  J Vasc Interv Radiol. 2010;  21 (8 Suppl) S192-203
• 8 Radvany M G, Allan P F, Frey W C, Banks K P, Malave D. Pulmonary radiofrequency ablation complicated by subcutaneous emphysema and pneumomediastinum treated with fibrin sealant injection.  AJR Am J Roentgenol. 2005;  185 (4) 894-898
• 9 Okuma T, Matsuoka T, Yamamoto A et al.. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.  Cardiovasc Intervent Radiol. 2008;  31 (1) 122-130
• 10 Pua B B, Thornton R H, Solomon S B. Ablation of pulmonary malignancy: current status.  J Vasc Interv Radiol. 2010;  21 (8, Suppl) S223-S232 Review
• 11 Abu-Hijleh M, Blundin M. Emergency use of an endobronchial one-way valve in the management of severe air leak and massive subcutaneous emphysema.  Lung. 2010;  188 (3) 253-257
• 12 Lois M, Noppen M. Bronchopleural fistulas: an overview of the problem with special focus on endoscopic management.  Chest. 2005;  128 (6) 3955-3965
• 13 Baumann M H, Strange C, Heffner J E AACP Pneumothorax Consensus Group et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement.  Chest. 2001;  119 (2) 590-602
• 14 Sakurai J, Hiraki T, Mukai T et al.. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors.  J Vasc Interv Radiol. 2007;  18 (1 Pt 1) 141-145